Select Bibliography

Filter by any of these (after searching):

Navari, Rudolph M.

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 3 items

Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or Vomiting

Navari, Rudolph M. , Pywell, Cameron M. , Le-Rademacher, Jennifer G. ... - - JAMA Oncol - 2020

Manuscript - Primary - Primary - Symptom Inter - Pilot , NCT03137121

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Navari, Rudolph M. , Qin, Rui , Ruddy, Kathryn J. , Liu, Heshan ... - - N Engl J Med - 2016

Manuscript - Primary - Primary - Symptom Inter - Alliance-A221301

Olanzapine For The Prevention Of Chemotherapy Induced Nausea And Vomiting (CINV) In Patients Receiving Highly Emetogenic Chemotherapy (HEC): Alliance A221301 A Randomized, Double-Blind, Placebo-Controlled Trial

Navari, Rudolph M. , Qin, Rui , Ruddy, Kathryn J. , Liu, Heshan ... - ASCO Pal - J Clin Oncol - 2015

Abstract - Primary - Primary - Symptom Inter - Alliance-A221301